Canada’s healthcare and pharmaceutical sector is booming. During the past 52 weeks small-cap healthcare companies in that country have reached 71, with a total market cap of $12.5 billion, a 47% year-over-year gain. And the winners have been winning big, with almost two fifths of the industry doubling in size. Today, SmallCapPower has shortlisted four of the biggest small and micro-cap gainers in this space during the past year.
Mettrum Health Corp. (TSXV: MT) – $1.90
Pharmaceuticals
Mettrum Health Corporation, formerly Cinaport Acquisition Corporation, is a Canada-based licensed producer of medicinal cannabis. The Company is a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of medical cannabis products to the Canadian market. Mettrum is the third company in Canada to receive a license under the Marijuana for Medical Purposes Regulations (MMPR). From its fully integrated medical grade facility located in Bowmanville, Ontario, Mettrum begun sales of medical cannabis under the MMPR.
- Market Cap: $64,164,675
- Market Cap Gain (1 Year): 52,580%
- Revenues (Last Quarter): $689,480
Bedrocan Cannabis Corp. (TSXV: BED) – $0.76
Pharmaceuticals
Bedrocan Cannabis Corp., formerly POCML 2 Inc., is a Canada-based Company. The Company completed its qualifying transaction by acquiring Bedrocan Canada Inc. The Company operates through its subsidiary, Bedrocan Canada Inc. (Bedrocan). Bedrocan is engaged in the business of importing and supplying medical marijuana. Bedrocan holds a license to sell medical marijuana from Health Canada. Effective August 21, 2014, POCML 2 Inc acquired Bedrocan Canada Inc.
- Market Cap: $52,623,506
- Market Cap Gain (1 Year): 5,558%
- Revenues (Last Quarter): $493,360
OrganiGram Holdings Inc. (TSXV: OGI) – $0.54
Pharmaceuticals
OrganiGram Holdings Inc., formerly Inform Exploration Corp. is a Canada-based holding company. The Company, through its subsidiary, OrganiGram Inc. is engaged in the licensed production of medical marihuana. The OrganiGram suite of Medical Marijuana consists of fourteen strains of marijuana, such as Mongolian, AK-47, B.C. Godbud and CBD Critical Mass. OrganiGram’s facility is located in Moncton, New Brunswick.
- Market Cap: $28,663,838
- Market Cap Gain (1 Year): 5,218%
- Revenues (Last Quarter): $13,120
Premier Diagnostic Health Services Inc. (CSE: PDH) – $0.25
Healthcare Facilities & Services
Premier Diagnostic Health Services Inc. is a Canada-based company, engaged in the business of establishing Diagnostic Imaging Centers in Canada and China, together with an integrated support services infrastructure, utilizing of Positron Emission Technology (PET) and/or Magnetic Resonance Imagining (MRI) technologies, and the establishment of facilities for the commercial production of Health Canada-approved CanTrace fluorodeoxyglucose (FDG), the radiopharmaceutical used in PET scanning, for use and sale. As of September 30, 2012, it had 100% interest in Premier Diagnostic Health Services (Vancouver) Inc.; Petscan International (Hong Kong) Limited, and Beijing Premier International Medical Equipment Technology Services Corporation Limited (Premier Beijing). In June 2014, the Company completed the reorganization, which involved transfer of all of medical diagnostic equipment and assets of the Company’s Vancouver diagnostic clinic to Premier Diagnostic Center (Vancouver) Inc.
- Market Cap: $31,973,261
- Market Cap Gain (1 Year): 3,946%
- Revenues (Last Quarter): $301,000
